Prestige Consumer Healthcare (PBH) Total Debt Growth (5y) (2016 - 2025)
Prestige Consumer Healthcare (PBH) Total Debt Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.19 Bn | 87.33 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn |
| 3 | Zoetis | 32.52 Bn | 30.58 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.22 Bn | 21.07 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.29 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.72 Bn | 16.40 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.38 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.77% |
| Sep 30, 2025 | -8.50% |
| Jun 30, 2025 | -9.34% |
| Mar 31, 2025 | -10.52% |
| Dec 31, 2024 | -10.23% |
| Sep 30, 2024 | -9.73% |
| Jun 30, 2024 | -9.32% |
| Mar 31, 2024 | -8.94% |
| Dec 31, 2023 | -8.23% |
| Sep 30, 2023 | -7.80% |
| Jun 30, 2023 | -7.96% |
| Mar 31, 2023 | -7.55% |
| Dec 31, 2022 | -7.27% |
| Sep 30, 2022 | -7.44% |
| Jun 30, 2022 | -7.25% |
| Mar 31, 2022 | -7.61% |
| Dec 31, 2021 | 1.27% |
| Sep 30, 2021 | 1.56% |
| Jun 30, 2021 | -0.41% |
| Mar 31, 2021 | -2.19% |